This dedicated bioreactor system is designed for adherent cell large-scale expansion relying on microcarrier suspension culture, perfectly suited for vaccine seed cells, mammalian adherent cell lines, gene therapy packaging cells and primary cell mass propagation in biopharmaceutical industrial production.
The vessel and wetted pipelines adopt electropolished 316L stainless steel, supporting automated CIP and SIP cycles with validated E&L test results, fully meeting cGMP aseptic production requirements. The optimized low-shear stirring mechanism and baffle layout guarantee uniform suspension of microcarriers throughout the cultivation tank without sedimentation or carrier aggregation, while avoiding excessive shear damage to adherent cells attached to microcarrier surfaces.
Precise closed-loop control of dissolved oxygen, pH, temperature, agitation speed and overlay gas mixing creates a stable growth microenvironment. The system supports controlled medium perfusion, nutrient supplementation and waste metabolite removal, enabling long-term continuous cultivation and multi-layer cell proliferation on microcarriers, greatly amplifying total cell yield compared with traditional cell factory culture.
The automation framework follows ISA-88 batch standards, stores multiple cell expansion process recipes, executes unattended running, records full-process trend data and generates complete audit trails for regulatory inspection and filing. Consistent kLa and geometric scale-up design enables seamless process migration from lab small-scale trials, pilot verification to commercial large-volume production.
The whole system can be inline matched with subsequent cell harvesting, dissociation, clarification and purification equipment to form a closed integrated workflow. It drastically reduces manual operation and contamination risks, cuts workshop footprint and production costs, becoming the mainstream scalable solution for adherent cell industrial amplification for viral vaccines and cell therapy products.
